Similar -Synuclein staining in the colon mucosa in patients with Parkinson's disease and controls

被引:40
作者
Antunes, Laurent [1 ]
Frasquilho, Sonia [1 ]
Ostaszewski, Marek [1 ,2 ]
Weber, Jos. [3 ]
Longhino, Laura [4 ]
Antony, Paul [2 ]
Baumuratov, Aidos [2 ]
Buttini, Manuel [2 ]
Shannon, Kathleen M. [5 ]
Balling, Rudi [2 ]
Diederich, Nico J. [2 ,4 ]
机构
[1] Integrated Biobank Luxembourg, Dept Pathol, Luxembourg, Luxembourg
[2] Ctr Hosp Luxembourg, Dept Gastroenterol, Luxembourg, Luxembourg
[3] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg
[4] Ctr Hosp Luxembourg, Dept Neurol, 4 Rue Barble, L-1210 Luxembourg, Luxembourg
[5] Rush Univ, Dept Neurol Sci, Chicago, IL 60612 USA
关键词
Parkinson's disease; alpha-synuclein; mucosa; colon; biomarker; ENTERIC NERVOUS-SYSTEM; ALPHA-SYNUCLEIN; LACKS SPECIFICITY; BIOMARKER; PATHOLOGY;
D O I
10.1002/mds.26702
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundThe gut is proposed as a starting point of idiopathic IPD, but the presence of -synuclein in the IPD colon mucosa is debated. ObjectivesThe objective of this study was to evaluate if -synuclein in the colon mucosa can serve as a biomarker of IPD. MethodsImmunohistochemistry was used to locate and quantify in a blinded approach -synuclein in the mucosa from biopsies of the right and left colon in 19 IPD patients and 8 controls. ResultsTotal -synuclein was present in all but 1 IPD patients and in all controls; phosphorylated -synuclein was present in all subjects. There was no intensity difference depending on disease status. Staining of total -synuclein was stronger in the right colon (p = .04). ConclusionsConventional immunohistochemistry -synuclein staining in colon mucosal biopsies cannot serve as a biomarker of idiopathic PD. These findings do not contradict the assumption of disease starting in the colon, and a colon segment-specific risk for disease initiation can still be hypothesized. (c) 2016 International Parkinson and Movement Disorder Society
引用
收藏
页码:1567 / 1570
页数:4
相关论文
共 20 条
[1]   Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders [J].
Beach, Thomas G. ;
Adler, Charles H. ;
Sue, Lucia I. ;
Vedders, Linda ;
Lue, LihFen ;
White, Charles L., III ;
Akiyama, Haru ;
Caviness, John N. ;
Shill, Holly A. ;
Sabbagh, Marwan N. ;
Walker, Douglas G. .
ACTA NEUROPATHOLOGICA, 2010, 119 (06) :689-702
[2]   Expression pattern and localization of alpha-synuclein in the human enteric nervous system [J].
Boettner, Martina ;
Zorenkov, Dimitri ;
Hellwig, Ines ;
Barrenschee, Martina ;
Harde, Jonas ;
Fricke, Tobias ;
Deuschl, Guenther ;
Egberts, Jan-Hendrik ;
Becker, Thomas ;
Fritscher-Ravens, Annette ;
Arlt, Alexander ;
Wedel, Thilo .
NEUROBIOLOGY OF DISEASE, 2012, 48 (03) :474-480
[3]   Idiopathic Parkinson's disease:: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen [J].
Braak, H ;
Rüb, U ;
Gai, WP ;
Del Tredici, K .
JOURNAL OF NEURAL TRANSMISSION, 2003, 110 (05) :517-536
[4]   Alpha-synuclein in gastric and colonic mucosa in Parkinson's disease: Limited role as a biomarker [J].
Chung, Sun Ju ;
Kim, Juyeon ;
Lee, Hyo Jeong ;
Ryu, Ho-Sung ;
Kim, Kiju ;
Lee, Jeong Hoon ;
Jung, Kee Wook ;
Kim, Mi Jung ;
Kim, Mi-Jung ;
Kim, Young Jin ;
Yun, Sung-Cheol ;
Lee, Joo-Yong ;
Hong, Seung-Mo ;
Myung, Seung-Jae .
MOVEMENT DISORDERS, 2016, 31 (02) :241-249
[5]   Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations [J].
Dehay, Benjamin ;
Bourdenx, Mathieu ;
Gorry, Philippe ;
Przedborski, Serge ;
Vila, Miquel ;
Hunot, Stephane ;
Singleton, Andrew ;
Olanow, C. Warren ;
Merchant, Kalpana M. ;
Bezard, Erwan ;
Petsko, Gregory A. ;
Meissner, Wassilios G. .
LANCET NEUROLOGY, 2015, 14 (08) :855-866
[6]   Discriminative Power of Different Nonmotor Signs in Early Parkinson's Disease. A Case-Control Study [J].
Diederich, Nico J. ;
Pieri, Vannina ;
Hipp, Geraldine ;
Rufra, Olivier ;
Blyth, Sara ;
Vaillant, Michel .
MOVEMENT DISORDERS, 2010, 25 (07) :882-887
[7]   Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease [J].
Forsyth, Christopher B. ;
Shannon, Kathleen M. ;
Kordower, Jeffrey H. ;
Voigt, Robin M. ;
Shaikh, Maliha ;
Jaglin, Jean A. ;
Estes, Jacob D. ;
Dodiya, Hemraj B. ;
Keshavarzian, Ali .
PLOS ONE, 2011, 6 (12)
[8]   Multiple Organ Involvement by Alpha-Synuclein Pathology in Lewy Body Disorders [J].
Gelpi, Ellen ;
Navarro-Otano, Judith ;
Tolosa, Eduardo ;
Gaig, Carles ;
Compta, Yaroslau ;
Jesus Rey, Maria ;
Jose Marti, Maria ;
Hernandez, Isabel ;
Valldeoriola, Francesc ;
Rene, Ramon ;
Ribalta, Teresa .
MOVEMENT DISORDERS, 2014, 29 (08) :1010-1018
[9]   Alpha-Synuclein in the Appendiceal Mucosa of Neurologically Intact Subjects [J].
Gray, Madison T. ;
Munoz, David G. ;
Gray, Douglas A. ;
Schlossmacher, Michael G. ;
Woulfe, John M. .
MOVEMENT DISORDERS, 2014, 29 (08) :991-998
[10]   Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease [J].
Hilton, David ;
Stephens, Madeleine ;
Kirk, Leanne ;
Edwards, Philip ;
Potter, Ross ;
Zajicek, John ;
Broughton, Ellie ;
Hagan, Hannah ;
Carroll, Camille .
ACTA NEUROPATHOLOGICA, 2014, 127 (02) :235-241